On September 8, in Irkutsk, as part of the VII All-Russian GMP Conference with International Participation, an extended master class on good manufacturing practices and GMP inspections will be held.
For the sixth year in a row, the All-Russian GMP Conference brings together representatives of pharmaceutical industry from Russia, member states of the Eurasian Economic Union, countries of the near and far abroad.
The Conference opened with a plenary session under the motto “Strong Regulator – Strong Industry” moderated by Dmitry Galkin, Director of the Department of Development of Pharmaceutical and Medical Industry of the Ministry of Industry and Trade of Russia, and Vladislav Shestakov, Director of the Federal State Institution «State Institute of Drugs and Good Practices» of the Ministry of Industry and Trade of Russia (FSI «SID & GP»).
The Ultrix Quadri vaccine produced by the Nacimbio Holding of Rostec State Corporation has been approved by the Russian Ministry of Health for the vaccination of people over 60 years of age.
Roche has been a strategic partner of the All-Russia GMP Conference for several years and will be supporting the event in 2021.
Petrovax will act as a partner in a panel discussion dedicated to regulating the circulation of medicinal products within the EAEU, to be held as part of the 6th All-Russian GMP Conference with International Participants on 23 September 2021.
The Nacimbio Holding Company of the Rostec State Corporation encompasses biopharmaceutical enterprises specialising in development, production, and marketing of biological drug products, and organises the vaccine supply within all Russian regions.
The “Best Technical Director” competition is held within the framework of the VI All-Russian GMP Conference with International Participation, which will take place on September 22-24, 2021 in a hybrid format and consists of two stages.